2022

When does a pandemic become endemic – and what is the difference?


Dr. Timothy Brewer, UCLA Fielding School of Public Health professor of epidemiology, addresses the status of COVID-19.

COVID-19 virus close-up with crowd of people in the background

The omicron variant provides clues about COVID-19’s trajectory

Though omicron is infecting a record number of people around the world, for those who’ve been vaccinated against COVID-19 and received a booster shot, a bout with the variant is likely to feel like an ordinary cold.

This could be a promising development in the pandemic’s trajectory.

“When we look back 10 years from now, I think the emergence of omicron will be considered a hallmark event, because it really brings the light at the end of the tunnel,” said UCLA Health pathologist Dr. Shangxin Yang. “We potentially can see how the pandemic might end and become endemic.”

The World Health Organization declared COVID-19 a pandemic — an illness that spreads exponentially — in March of 2020. The virus known as SARS-CoV-2 spread from Wuhan, China, across the globe within months, killing more than 5.5 million people to date.

An endemic disease, on the other hand, is one with more predictable rates of circulation, according to Dr. Mike Ryan, executive director of the WHO Health Emergencies Program. Colds and flu, for instance, are endemic, circulating every winter.

But given the high levels of transmissibility of SARS-CoV-2, the virus that causes COVID-19, some experts consider COVID to be endemic already.

“This virus is so well adapted for human-to-human transmission that it’s going to be very difficult, if not impossible, to ever get rid of it completely,” said Dr. Timothy Brewer, UCLA Fielding School of Public Health professor of epidemiology, noting diseases that aren’t eradicated are, by definition, endemic.

Regardless of how you classify it, COVID-19 isn’t going away.

How previous pandemics evolved

Yang points to the swine flu pandemic as an example of one disease’s trajectory from pandemic to endemic.

When the swine flu emerged in 2009, no one had immunity to it. The disease was a version of the H1N1 influenza virus — the same one that caused the 1918 flu pandemic — that hopped from people to pigs and and birds and back again, with multiple viral genome reassortment along the way. By the time it began spreading among the human population in spring of 2009, the virus had elements that originated from people, pigs and birds in it, Yang said, “reassembled to create a brand-new virus.”

Like COVID-19, the disease spread quickly across the globe and struck in waves similar to the surges we’ve experienced over the past two years.

Scientists were able to develop a vaccine against swine flu very quickly, Yang said, relying on a well-established annual vaccination program against influenza. Plus, swine flu wasn’t as deadly as COVID, so there were plenty of survivors who developed natural immunity.

“By winter of 2009, most people were either infected or vaccinated, so that you quickly had herd immunity across the globe,” Yang said, meaning enough people had been exposed to the virus that they acquired some protection against severe illness. “Therefore, by August of 2010 — basically a little bit over a year — the pandemic ended. But the virus didn’t go away. The virus became endemic. It basically just became a new seasonal flu.”

Another possibility is that COVID-19 could follow a trajectory more like the HIV pandemic, Brewer suggested. HIV is just as deadly and no less contagious today than it was when it emerged 40 years ago, but treatment and prevention for the disease have improved dramatically.

“There’s nothing to say that SARS-CoV-2 has to become less pathogenic to become endemic,” he said. “What determines whether or not it’s going to be endemic is how well it spreads from person to person, and it does that very well.”

The future of COVID-19

The expeditious spread of the omicron variant — more than 700,000 new cases every day in the U.S. during the winter 2022 surge — means many, many more people will acquire some level of immunity to COVID-19. Omicron is still deadly in certain populations, including unvaccinated or immunocompromised individuals, but hospitalization and death rates have declined compared with previous variants of the virus.

But does this mean COVID is now endemic, or is this a step in that direction?

“I think after this surge, most people on Earth would either be vaccinated or infected. Therefore, the whole global population would gain herd immunity,” Yang said, “which would make the SARS-CoV-2 virus become endemic.”

Yang envisions a future where SARS-CoV-2 might behave like the flu or the common cold — a seasonal illness that’s more of a nuisance rather than a life-threatening condition. The season flu, however, remains life-threatening to some, leading to tens of thousands of deaths annually in the U.S.

The increased immunity against COVID-19 provided by vaccines, boosters and the widespread omicron variant could slow the appearance of future variants, Brewer said.

“As immunity rises in the population, case numbers will begin to fall because there'll be fewer and fewer susceptible individuals for that particular variant to infect,” he said.

The eventual decline in COVID-19 case numbers, combined with new medications — including antiviral pills recently authorized by the U.S. Food and Drug Administration — and expertise in treating the virus gained over the course of the coronavirus pandemic could enable health care systems to better accommodate people who do become infected.

The next variant?

Any future variant would have to be more transmissible or more evasive of our current immunity — or both — to supplant omicron, Brewer said, adding that each new variant needs to displace the previous one to take hold.

But it’s important to note that transmissibility (how easily the virus spreads), immune escape (how well it evades protection from vaccination or previous infection) and pathogenicity (severity of disease) are independent properties.

“You can have a variant that has immune escape that is more pathogenic or less pathogenic,” Brewer said. Omicron, he notes, was more contagious and more evasive of immunity than its predecessor, the delta variant, but less pathogenic.

One big question mark is the role animals might play in the evolution of future variants, Yang added.

“It’s unclear yet whether SARS-CoV-2 has a large animal reservoir and that animal strain of the virus could spill back to humans and cause kind of a continuous pandemic,” he said. “That’s yet to be determined.”

For example, COVID-19 spread rapidly among farmed mink in many parts of Europe in 2020 and the variant was able to infect people as well. A more recent study found the virus spread easily among white-tail deer in Ohio, but didn’t transmit back to humans.

“The zoonotic reservoir is an unpredictable factor in this equation,” Yang said.

The most recent flu pandemics, including swine flu, were created by the virus mutating in animals and then infecting people.

“From a more optimistic standpoint, we are hoping that omicron will be the last major variant that could end the pandemic,” Dr. Yang says. “Obviously, we need time to see that.”

If omicron is, indeed, the last variant in SARS-CoV-2’s trajectory, it would “join the long list of human pathogens” and cause seasonal illness similar to the cold symptoms caused by other regularly circulating coronaviruses, he says.

“That’s kind of how I see it ending,” Dr. Yang says. “I’m hoping that very likely this will end this year, presumably summer. But we’ll see.”

by Sandy Cohen

Faculty Referenced by this Article

Dr. Timothy Brewer
Timothy Brewer
Epidemiology
Read Faculty Profile
Otoniel Martinez-Maza
Otoniel Martinez-Maza
Epidemiology
Read Faculty Profile
Headshot
Christie Jeon
Epidemiology
Read Faculty Profile
Marissa J. Seamans
Marissa Seamans
Epidemiology
Read Faculty Profile
DerSarkissian, Maral
Maral DerSarkissian
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Jørn Olsen
Epidemiology
Read Faculty Profile
Haroutune Armenian
Haroutune Armenian
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Ondine S. von Ehrenstein
Community Health Sciences Epidemiology
Read Faculty Profile
Alexandra Binder Headshot
Alexandra Binder
Epidemiology
Read Faculty Profile
Dr. Marjan Javanbakht
Marjan Javanbakht
Epidemiology
Read Faculty Profile
Paul Simon Headshot
Paul Simon
Epidemiology
Read Faculty Profile
Dr. Anne Rimoin
Anne Rimoin
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Frank J. Sorvillo
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Catherine Carpenter
Epidemiology
Read Faculty Profile
Dr. Dvora Joseph Davey
Dvora Joseph Davey

Dr. Joseph Davey is an infectious disease epidemiologist with over 20 years' experience leading research on HIV/STI services for women and children.

Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Nicole Hoff
Epidemiology
Read Faculty Profile
Dr. Shira Shafir
Shira Shafir
Community Health Sciences Epidemiology
Read Faculty Profile
sheena sullivan photo
Sheena G. Sullivan
Epidemiology
Read Faculty Profile
Tony Kuo
Tony Kuo
Epidemiology
Read Faculty Profile
Aziz, Najib headshot_2023
Najib Aziz
Epidemiology
Read Faculty Profile
Ximena Vergara
Ximena Vergara
Epidemiology
Read Faculty Profile
Kamyar Kalantar-Zadeh
Kamyar Kalantar-Zadeh
Epidemiology
Read Faculty Profile
Elizabeth Rose Mayeda photo
Elizabeth Rose Mayeda
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Roberta Malmgren
Epidemiology
Read Faculty Profile
Dr. Beate Ritz
Beate Ritz
Environmental Health Sciences Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Leeka I. Kheifets
Epidemiology
Read Faculty Profile
Jonathan Jacobs
Jonathan Jacobs
Epidemiology
Read Faculty Profile
Dr. Brian Bradbury
Brian Bradbury
Epidemiology
Read Faculty Profile
Nathan Wong
Nathan D. Wong
Epidemiology
Read Faculty Profile
Dr. Liwei Chen
Liwei Chen

Professor in Epidemiology

Epidemiology
Read Faculty Profile
Robert Kim-Farley
Robert J. Kim-Farley

Robert J. Kim-Farley, MD, MPH, is a Professor-in-Residence with joint appointments in the Departments of Epidemiology and Community Health Sciences

Community Health Sciences Epidemiology
Read Faculty Profile
Naomi Greene
Naomi Greene
Epidemiology
Read Faculty Profile
Dr. Roger Detels
Roger Detels
Epidemiology
Read Faculty Profile
Onyebuchi Arah headshot
Onyebuchi A. Arah
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Niklas Krause
Environmental Health Sciences Epidemiology
Read Faculty Profile
Ralph R. Frerichs, 12/25/21
Ralph R. Frerichs
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Kelika Konda
Epidemiology
Read Faculty Profile
Pamina Gorbach
Pamina Gorbach
Epidemiology
Read Faculty Profile
Roch Nianogo
Roch A. Nianogo
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Annette Regan
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Lawrence Ash
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Teresa Ellen Seeman
Epidemiology
Read Faculty Profile
Jian Li
Jian Li
Environmental Health Sciences Epidemiology
Read Faculty Profile
Sung-Jae Lee
Sung-Jae Lee
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Paul Dluzniewski
Epidemiology
Read Faculty Profile
Sander Greenland
Sander Greenland
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Dallas Swendeman
Epidemiology
Read Faculty Profile
Dr. Paul Hsu
Paul Hsu
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Emily Beeler
Epidemiology
Read Faculty Profile
Woman dressed in blue and wearing pearls and eye glasses
Lisa V. Smith
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Vonthanak Saphonn
Epidemiology
Read Faculty Profile
Jody Heymann
Jody Heymann
Epidemiology Health Policy and Management
Read Faculty Profile
Susan Cochran
Susan Cochran
Epidemiology
Read Faculty Profile
Akihiro Nishi Headshot
Akihiro Nishi
Epidemiology
Read Faculty Profile
Dr. Zuo-Feng Zhang
Zuo-Feng Zhang
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Jian Yu Rao
Epidemiology
Read Faculty Profile
Bailley, Julia
Julia Bailey
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Peter R. Kerndt
Epidemiology
Read Faculty Profile
Karin Michels
Karin B. Michels
Epidemiology
Read Faculty Profile
Anne Coleman
Anne Coleman
Epidemiology
Read Faculty Profile
Matthew Mimiaga
Matthew J. Mimiaga
Epidemiology
Read Faculty Profile
Hashibe, Mia
Mia Hashibe
Epidemiology
Read Faculty Profile
Julia Heck
Julia Heck
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Peter Katona
Epidemiology
Read Faculty Profile
Su Yong Jung
Su Yon Jung
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Noel Weiss
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Amy Wohl
Epidemiology
Read Faculty Profile
Faculty/staff profile placeholder image
Nina Harawa
Epidemiology
Read Faculty Profile

Related Content

Clarivate+researchers
November 16, 2023
UCLA Fielding faculty listed among world’s most influential researchers
Read Full Article
September 7, 2023
"COVID is here. We have to continue to live with it."

CNN Newsroom interviewed Dr. Anne Rimoin, UCLA Fielding School of Public Health professor of epidemiology and the Gordon-Levin Endowed Chair in Infectious Diseases and Public Health, about continuing to live with and prevent the spread of COVID-19 and its subsequent variants.

Read Full Article